DTNBP1 gene expression was significantly increased in a variety of cancers, including acute myeloid leukemia (AML), breast cancer, colon cancer, liver cancer, lung cancer, ovary cancer, pancreatic cancer, rectal cancer, renal cancer, skin cancer, thyroid cancer, and uterine cancer (Figure 2A). Here, DTNBP1 is linked to lung cancer.